Results 211 to 220 of about 647,511 (278)

[Pulmonary surfactant].

La Revue du praticien, 1980
M, Garrigues, A, Neidhart, J, Vanche
openaire   +3 more sources

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases. [PDF]

Drugs
Giri BR, Spahn JE, Alsaidalani R, Behrend-Keim B, Bhia M, Doyle JH, Herpin MJ, Moore RC, Murali NS, Safak A, Smyth HDC.   +10 more
europepmc   +1 more source

Rational design of lipid-based nanoparticles for targeted anticancer therapies. [PDF]

Drug Deliv Transl Res
Arenas-Moreira M, Ocaña A, Alonso-Moreno C, Bravo I.   +3 more
europepmc   +1 more source

Shikonin: From Biosynthesis and Pharmacological Mechanisms to Translational Safety and Drug Delivery

ChemBioChem, Volume 27, Issue 21, 12 November 2026.
Shikonin, biosynthesised in Boraginaceae roots from phenylalanine‐derived PHB and isoprenoid GPP, modulates redox balance, cellular stress, signalling pathways, and regulated cell death. Preclinical studies support diverse pharmacological activities, while nanocarriers improve dispersion and delivery.
Namini Joshi, Prabhakar Semwal, Balwant Rawat, Ravendra Kumar, Mozaniel Santana de Oliveira, Nishant Rai, Janhvi Mishra Rawat   +6 more
wiley   +1 more source

Circulating Bubbles in Decompression Sickness: Pathophysiology and Experimental Models. [PDF]

Biomolecules
Jin Z, Zhu Q, Zheng J, Zhu B, Zhang K, Huang G, Yu X, Xu W.   +7 more
europepmc   +1 more source

Microfluidic Nano‐Assembly of Red‐Blood‐Cell (RBC) Lipids and Components for Engineering Extracellular Vesicles

Advanced Healthcare Materials, Volume 15, Issue 41, 6 November 2026.
Engineered red blood cell‐derived extracellular vesicles (eRBCEVs) are synthesized via controlled microfluidic assembly from native RBC lipids, enabling tunable encapsulation of proteins, nucleic acids, nanoparticles, and viral vectors. The platform demonstrates reproducible nanoscale architecture, preserved membrane composition, and functional cargo ...
Chiranth K. Nagaraj, Xilal Y. Rima, Kim T. Nguyen, Courtney Culkins, Nana Boateng, Jacob Doon‐Ralls, Alejandro Bresolin, Xin Huang, Hong Li, Vahedi Amid, Ajeet Pal Singh, Dharti Shantaram, Anastasiia Amari, Mangesh D. Hade, Nicholas R. Merriam, Zachary D. Schultz, Scott Q. Harper, Nizar Y. Saad, Setty M. Magaña, Willa A. Hsueh, Rachel E. Kopec, Blaise R. Kimmel, Andre F. Palmer, Eduardo Reátegui   +23 more
wiley   +1 more source

A novel inhalable tanshinone IIA lipid nanocrystal formulation for the enhanced treatment of idiopathic pulmonary fibrosis. [PDF]

J Nanobiotechnology
Wang Q, Zhao Y, Mao Y, Zhang X, Huang L, Tang L, Chen Y, Gong Z, Peng J.   +8 more
europepmc   +1 more source

Comparison of the effect of surfactant with and without budesonide on the outcomes of respiratory distress syndrome (RDS) in premature infants: a randomized control trial. [PDF]

BMC Pregnancy Childbirth
Jamali Z, Molaei-Farsangi MH, Ahmadipour H, Sharifi L, Karami Robati F, Bahmanbijari B, Sabzevari F, Eslamian M, Nikvarz M.   +8 more
europepmc   +1 more source

Mechanistic Insights into Pulmonary Surfactant Inactivation. [PDF]

Langmuir
Novaes-Silva MC, Rodríguez-Hakim M, Vermant J.   +2 more
europepmc   +1 more source

Inhalation-Based Nanoparticle Drug Delivery Targeting the Diseased Lower Airways in Idiopathic Pulmonary Fibrosis. [PDF]

Pharmaceutics
Lee JW, Skibba M, Tang T, Noh H, Brasier AR, Hong S.   +5 more
europepmc   +1 more source